Divestments and Acquisitions: A Changing Landscape
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 69 (Table of Contents)
Published: 1 Mar-2006
DOI: 10.3833/pdr.v2006.i69.543 ISSN: 1756-7874
Section: Features
Fulltext:
Abstract
In February 2006, Croatian pharmaceutical company PLIVA announced that it is to sell its Zagreb R&D unit to GlaxoSmithKline so that it can concentrate on the generics side of its business...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS